Guardant Health (GH) EPS (Weighted Average and Diluted) (2019 - 2025)
Historic EPS (Weighted Average and Diluted) for Guardant Health (GH) over the last 7 years, with Q3 2025 value amounting to -$0.74.
- Guardant Health's EPS (Weighted Average and Diluted) rose 1590.91% to -$0.74 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.21, marking a year-over-year increase of 2500.0%. This contributed to the annual value of -$3.56 for FY2024, which is 1693.65% up from last year.
- Latest data reveals that Guardant Health reported EPS (Weighted Average and Diluted) of -$0.74 as of Q3 2025, which was up 1590.91% from -$0.8 recorded in Q2 2025.
- Guardant Health's 5-year EPS (Weighted Average and Diluted) high stood at -$0.67 for Q2 2023, and its period low was -$2.25 during Q2 2022.
- Its 5-year average for EPS (Weighted Average and Diluted) is -$1.08, with a median of -$0.94 in 2024.
- In the last 5 years, Guardant Health's EPS (Weighted Average and Diluted) tumbled by 13437.5% in 2022 and then soared by 7022.22% in 2023.
- Quarter analysis of 5 years shows Guardant Health's EPS (Weighted Average and Diluted) stood at -$0.89 in 2021, then tumbled by 53.93% to -$1.37 in 2022, then decreased by 18.25% to -$1.62 in 2023, then skyrocketed by 44.18% to -$0.9 in 2024, then increased by 18.17% to -$0.74 in 2025.
- Its last three reported values are -$0.74 in Q3 2025, -$0.8 for Q2 2025, and -$0.77 during Q1 2025.